Tag: INSY

  • Healthcare 20% Gainers – Questcor Pharmaceuticals (NASDAQ:QCOR), Arena Pharmaceuticals (NASDAQ:ARNA), Chelsea Therapeutics International (NASDAQ:CHTP), Insys Therapeutics (INSY)

    Questcor Pharmaceuticals Inc (NASDAQ:QCOR) participated in the 32ndannual J.P. Morgan Healthcare Conference. Questcor mentioned at the conference that it is looking to adopt business development activity owing to its huge cash flow. The company is contemplating many options that include going private, possible acquisitions and/or partnerships. Investors reacted positively with the share price surging 11.2%. Questcor Pharmaceuticals Inc (NASDAQ:QCOR) stock opened at $61.79 in last session, and closed at $59.32, while the day range of stock is $58.84 – $63.30. The stock showed a positive weekly performance of 12.65%.

    Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) advanced 5.61%, extending gains as shares might be getting some interest following its presentation at the 32nd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2014, at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) at The Westin St. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) stock opened at $7.84, in last session and closed at $7.26, by losing -5.96%. The 52 week range of the stock is $4.05 – $10.30. Company’s market capitalization is $1.59 billion.

    Chelsea Therapeutics International Ltd. (NASDAQ:CHTP)added 6.58% yesterday, consolidating 104% rally in past 2 days after a panel of federal experts recommended the approval of its experimental blood pressure drug Northera, which is designed to prevent dizziness and fainting in Parkinson’s disease patients. Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) stock advanced 1.28% and finished the last session at $4.76. The EPS of the stock remained -0.20. Company’s market capitalization is $373.35 billion.

    Insys Therapeutics Inc (NASDAQ:INSY) CFO Darryl Baker sold 10,000 shares of the company’s stock in a transaction dated Thursday, January 16th. The stock was sold at an average price of $49.61, for a total transaction of $496,100.00. Insys Therapeutics Inc (NASDAQ:INSY) stock opened the session at $50.78, and closed the session at $53.81. The 52 week range of the stock remained $7.10 – $54.30 and the day range was $50.32 – $54.30.